<?xml version="1.0" encoding="UTF-8"?>
<p>Crowell et al.
 <xref rid="CIT0075" ref-type="bibr">
  <sup>75</sup>
 </xref> extracted the monoterpenoid 
 <italic>d</italic>-limonene (
 <bold>58</bold>), one of the end products of the metabolism of mevalonate in plant cells, which is widely found in orange peel and some plant essential oils. Compound 
 <bold>58</bold> is one of the few natural anti-tumour products known to have both chemopreventive and chemotherapeutic effects. Besides, 
 <italic>d</italic>-limonene is also a very effective chemotherapeutic agent, which can cause 80% complete regression of rat breast cancer induced by chemical factors
 <xref rid="CIT0076" ref-type="bibr">
  <sup>76–78</sup>
 </xref>. Currently, 
 <italic>d</italic>-limonene has entered phase I clinical studies in the UK
 <xref rid="CIT0079" ref-type="bibr">
  <sup>79</sup>
 </xref>.
</p>
